Clinical Trial2020-01-30T17:41:51+00:00

Ayala is currently evaluating AL101 in our ongoing Phase 2 ACCURACY trial for the treatment of patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). We are also planning to hold Phase 2 trials of AL101 for the treatment of recurrent/metastatic triple negative breast cancer (R/M TNBC) and relapsed/refractory T-cell acute lymphoblastic leukemia (R/R T-ALL).

As part of our commitment, we are conducting clinical trials of our investigational medicines in order to demonstrate their safety and efficacy in cancer patients. Patients who choose to participate in clinical trials play a critical role in developing new medicines.

If you are interested in gaining access to our investigational medicines, please contact Ayala Medical at ClinicalTrials.gov_Accuracy@ayalapharma.com or +1-857-444-0553.